In addition to the effects of GLP-1/GLP-1R axis on metabolism, GLP-1R agonists (GLP-1RAs, such as liraglutide) also improved the markers of ovarian function (bleeding pattern; levels of AMH (Anti-Müllerian hormone)), sex hormones, gonadotropins, and ovarian morphology in overweight women with PCOS [9]. This evidence concerns the gene GCG and polycystic ovary syndrome.